COVID-19: the new challenge for rheumatologists

Affiliations

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
³ Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
⁴ University of Pisa, Italy. s.bombardieri@int.med.unipi.it.

Free article

Editorial

Francesco Ferro et al. Clin Exp Rheumatol. 2020 Mar-Apr.

Free article

. 2020 Mar-Apr;38(2):175-180.

doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
³ Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
⁴ University of Pisa, Italy. s.bombardieri@int.med.unipi.it.

No abstract available

Comment on

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M. Sarzi-Puttini P, et al. Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22. Clin Exp Rheumatol. 2020. PMID: 32202240 Review.
Therapies used in rheumatology with relevance to coronavirus disease 2019.
Pires da Rosa G, Ferreira E. Pires da Rosa G, et al. Clin Exp Rheumatol. 2020 Mar-Apr;38(2):370. doi: 10.55563/clinexprheumatol/vlncdz. Epub 2020 Mar 22. Clin Exp Rheumatol. 2020. PMID: 32202241 No abstract available.